M&A TRANSACTION · 2019
Chicago Prostate Cancer Surgery Center acquired by DuPage Medical Group
$2.5M· 1.20x revenue
Target
Chicago Prostate Cancer Surgery Center
Acquirer
DuPage Medical Group
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$2.1M
EBITDA
—
Deal Value
$2.5M
EV/EBITDA
—
Context
This $2.5M acquisition of Chicago Prostate Cancer Surgery Center by DuPage Medical Group sits in the ambulatory surgery center sub-vertical. DuPage Medical Group is acquiring as a strategic buyer; see how strategic acquirers typically price ambulatory surgery center businesses on our Ambulatory Surgery Center strategic buyer-pool page.
Source
Data sourced from CON filings. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own ambulatory surgery center
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Chicago Prostate Cancer Surgery Center acquisition.